{"id":183658,"date":"2024-03-10T15:56:46","date_gmt":"2024-03-10T07:56:46","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=534819"},"modified":"2024-03-10T15:56:46","modified_gmt":"2024-03-10T07:56:46","slug":"tracking-13fs-daniel-loebs-third-point-q4-2023","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2024\/03\/10\/tracking-13fs-daniel-loebs-third-point-q4-2023\/","title":{"rendered":"Tracking 13Fs: Daniel Loeb\u2019s Third Point Q4 2023"},"content":{"rendered":"<p>Larry Busacca<\/p>\n<p>In today&#8217;s article, we bring you the latest update in our recurring series based on analyzing 13F filings and the latest moves of some of the world&#8217;s most renowned funds and asset managers.&#8230;<\/p>\n<p><strong>This data comes from the <a href=\"https:\/\/www.chinapulse.com\/\" title=\"ChinaPulse.com provides Media Intelligence and Media Monitoring for China News\" >ChinaPulse.com media intelligence and smart news insights monitoring platform<\/a>.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Larry Busacca<br \/>\nIn today's article, we bring you the latest update in our recurring series based on analyzing 13F filings and the latest moves of some of the world's most renowned funds and asset managers.&#8230;<br \/>\nThis data comes from the Chin&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[144,213,586,671,113,693,1607,288,360,30,194,494,106,78,1284,64,1542,484],"tags":[2762,2263,2210,3472,5256,7327,6811,3479],"class_list":["post-183658","post","type-post","status-publish","format-standard","hentry","category-china","category-china-news","category-economy","category-finance","category-google","category-japan","category-manufacturing","category-medicine","category-microsoft","category-mobile","category-news-chinese-law","category-pharmaceutical","category-search-engine","category-software","category-stock-market","category-taiwan","category-technology","category-united-states","tag-acquisition","tag-amazon","tag-america","tag-chinese","tag-healthcare","tag-revenue","tag-semiconductor","tag-stocks"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/183658"}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=183658"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/183658\/revisions"}],"predecessor-version":[{"id":183659,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/183658\/revisions\/183659"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=183658"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=183658"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=183658"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}